doi: 10.1371/journal.pone.0053774 14 CioniJ
Adverse events of GLP-1 receptor agonists for weight loss: Twitter and a national pharmacovigilance database
In addition to dampening NF-B activity, KPV has been shown to downregulate the expression of adhesion molecules on endothelial and immune cells, limiting the recruitment and infiltration of leukocytes into inflamed tissues.(7) This targeted modulation extends to the suppression of pro-inflammatory cytokines such as interleukin-8 (IL-8) and tumor necrosis factor-alpha (TNF-), thereby mitigating excessive inflammatory cascades without broadly compromising host immune competence (8)
Mercier LA, Fortin A, Atto EJ, Lavoie KL (2023) The nature of expectations of bariatric surgery in patients during the pre- and post-operative period: a unicentric, qualitative study of patient perspectives
What the Research Shows About Missed Doses and Weight Loss Outcomes Clinical trials of semaglutide have not specifically isolated the effect of single missed doses, but observational data from real-world weight loss programs shows that patients with high medication adherence (95% of scheduled doses) achieve 1522% body weight reduction after one year, while those with lower adherence (7080%) typically achieve 812%